Compare LLYVA & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLYVA | ICLR |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | Ireland |
| Employees | 54700 | N/A |
| Industry | Broadcasting | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 9.3B |
| IPO Year | N/A | 2001 |
| Metric | LLYVA | ICLR |
|---|---|---|
| Price | $95.90 | $142.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $178.62 |
| AVG Volume (30 Days) | 202.7K | ★ 1.1M |
| Earning Date | 02-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.52 | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $74.38 | $66.57 |
| 52 Week High | $99.82 | $211.00 |
| Indicator | LLYVA | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 58.86 |
| Support Level | $86.31 | $99.11 |
| Resistance Level | $98.85 | $193.87 |
| Average True Range (ATR) | 3.24 | 6.84 |
| MACD | 0.26 | -0.84 |
| Stochastic Oscillator | 67.61 | 47.63 |
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.